Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

NCT02058108 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated on the recommendation of an independent Data Monitoring Committee (DMC) subsequent to an interim efficacy analysis for futility.\]

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals